Study regarding drugs in blood with ELISA and chemiluminiscence versus ELISA with spectrophotometric detection

Romanian Journal of Legal Medicine

Volumn 20, Issue 1, 2012, Pages 61-64

  Radu, Doina ^a   Aciu, Florina ^a   Constantin, Camelia ^a   Leauta, Ileana ^a   Dermengiu, Dan ^a,b   Hostiuc, Sorin ^a,b   Gorun, Gabriel Stefan ^a   Curca, George Cristian ^a,b  

^a NATIONAL INSTITUTE OF LEGAL MEDICINE MINA MINOVICI   (Romania)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Biochip Array Technology; Cannabinoids; Forensic toxicology; Opiates

Indexed keywords

BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BENZOYLECGONINE; CANNABINOID; OPIATE;

ARTICLE; BIOCHIP ARRAY TECHNOLOGY; BLOOD ANALYSIS; BLOOD SAMPLING; CHEMOLUMINESCENCE; DRUG SCREENING; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOASSAY; INTERMETHOD COMPARISON; MASS FRAGMENTOGRAPHY; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY;

EID: 84859044351     PISSN: 12218618     EISSN: 18448585     Source Type: Journal    
DOI: 10.4323/rjlm.2012.61     Document Type: Article

References (17)

1. Pragst F, Harzler M, Erxleben BT. Systematic toxicological analysis by high-performance liquid chromatography with diode array detection (HPLC-DAD). Clin Chem Lab Med. 2004;42(11):1325-1340
2. Meyer Lv, Schmoldt A, Külpmann WR. Klinisch-toxikologische Analytik: Verfahren, Befunde, Interpretation. Wiley 2002;287-297
3. Weinmann W, Renz M, Vogt S, Pollak S. Automated solid-phase extraction and two-step derivatisation for simultaneous analysis of basic illicit drugs in serum by GC/MS. Int J Legal Med, 2000;113:229-235
4. Kaeferstein H, Sticht G. Results of immunochemical and chromatographic investigations of blood samples in suspected drug abuse. 1. Report: Opiates, cocaine, cannabinoids, and amphetamines. Rechtsmedizin. 1998;8:173-177
5. Kaeferstein H, Sticht G. Comparison of MTP immunoassays with EMIT for the screening of drugs in blood samples Archiv fur Kriminologie 1998 Volume 202;5-6:165-172
6. Fitzgerald SP, Lamont JV, McConnell RI, Benchikh EO. Development of a High-Throughput-Automated Analyzer Using Biochip Array Technology. Clinical Chemistry. 2005;51:1165-1176
7. Orsulak PJ, Akers LC, Fuller D. Drug of abuse screening using the Randox Evidence Biochip Array Technology; 41stTiAFT Annual meeting, Melbourne, Australia, nov. 16-20, 2003
8. Felgate P, Thompson A, Kenneally M. The comparison of a new chemiluminescence immunoassay screen with a single-step enzyme linked immunosorbent assay (ELISA) TIAFT, Seattle, Washington, aug.26-30,2007
9. Evidence Biochip Array Technology Operator Manual, Version 2.0 Rev iune 2006, Randox Laboratories
10. Pudil R, Pařízek P, Tichý M, Haman L, Horáková L, Ulrychová M, Vojáček J, Palička V. Use of the biochip microarray system in detection of myocardial injury caused by radiofrequency catheter ablation. Clinical Chemistry and Laboratory Medicine, 2008. 46(12): p. 1726-1728.
11. Sypniewska G, Sawicki M, Krintus M, Kozinski M, Kubica J. The use of biochip cardiac array technology for early diagnosis of acute coronary syndromes. Journal of Medical Biochemistry, 2009. 28(4): p. 293-299.
12. Vašatová V, Tichý M, Horáček JM, Pudil R, Horáková L, Palička V. Multi-marker approach in the diagnostics of cardiac diseases by protein biochip technology. Multianalytový přístup k diagnostice srdečních chorob technologií proteinových biočipů, 2009. 148(12): p. 591-596.
13. Fabre S, Dupuy AM, Dossat N, et al. Protein biochip array technology for cytokine profiling predicts etanercept responsiveness in rheumatoid arthritis. Clinical and Experimental Immunology, 2008. 153(2): p. 188-195.
14. Fabre S, Guisset C, Tatem L, et al. Protein biochip array technology to monitor rituximab in rheumatoid arthritis. Clinical and Experimental Immunology, 2009. 155(3): p. 395-402.
15. Murray H, Latten M, Cartwright A, McAleer D, Fitzgerald S. Simultaneous detection of colorectal cancer mutations in stool samples with biochip arrays. Journal of Medical Biochemistry, 2009. 28(4): p. 285-292.
16. Maddalena AS, Papassotiropoulos A, Gonzalez-Agosti C, et al. Cerebrospinal fluid profile of amyloid β peptides in patients with Alzheimer's disease determined by protein biochip technology. Neurodegenerative Diseases, 2004. 1(4-5): p. 231-235.
17. Nitescu GV, Ulmeanu AI, Boghitoiu D, Petran ME, Ulmeanu CE. Ethnobotanical Substances-The New Recreational Drugs Used by Teenagers in Romania. Clinical Toxicology. 2011;49: 219.